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The Use of Stent Grafts for the Treatment of Aneurysms and
Dissections of the Thoracic Aorta: A Single Centre
Experience
P. Matravers,* R. Morgan and A. Belli
St Georges Hospital, Blackshaw Road, London SW17 0QT, UK
Objective. To review the results of stent graft treatment for diseases of the thoracic aorta.
Design. A retrospective study of the results of thoracic stent graft procedures in a single centre.
Methods. The results of 30 procedures performed in 24 patients were analysed. Eleven patients had aneurysmal dilatation of
the descending thoracic aorta (.5.5 cm), nine patients had complicated type B dissection, three had penetrating ulcers and
one had a traumatic pseudoaneurysm. Imaging follow-up consisted of CT scans performed at one, three, six and 12 months
following the procedure and annually thereafter.
Results. One technical failure occurred due to a ruptured external iliac artery. There were no other immediate failures. The
primary technical success rate was 83%. The 30-day procedural and patient mortality rates were 7 and 8%, respectively. No
neurological complications occurred. Seven patients had the subclavian artery covered without complications. Secondary
intervention was required in 21%. During the follow-up period (mean 11 months, range 1–48 months.) there were five
deaths, two of which were related to stent graft infection.
Conclusion. Thoracic stent grafts offer a realistic alternative to surgery.
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Introduction
Until recently, aneurysms of the distal aortic arch and
descending thoracic aorta have required surgical
treatment. Type B dissections have been managed
medically with surgery being reserved for those who
develop complications. The introduction of stent grafts
has opened up new options for the treatment of type B
dissections or aneurysmal disease of the descending
thoracic aorta, especially in those patients who are
considered poor surgical candidates.
We present our experience of thoracic stent grafts
for the treatment of aneurysms and dissections of the
thoracic aorta.
Materials and Methods
Thirty procedures were performed on 24 patients (16
men and 8 women) between November 1996 and
September 2002 (average age 71 years, range 53–81).
The indications for stent grafting were aneurysmal
dilatation of the descending thoracic aorta greater than
5.5 cm, smaller aneurysms with evidence of a leak,
penetrating ulcers and complicated type B dissections.
Exclusion criteria were a proximal or distal neck
shorter than 2 cm; and an aortic root diameter wider
than 4 cm (this is because the widest available device
measures 46 mm). Anatomically, lesions affected the
distal arch or descending thoracic aorta. All patients
had been turned down for surgical repair due to the
presence of significant co-morbidities.
All patients had pre-procedure CT scans of the
thoracic aorta. Scans were performed on a GE CTI
spiral scanner. Enhanced scans of the thoracic aorta
were performed following the injection of 100–150 ml
Iohexol 300 at 3 ml/s. A smart prep protocol was used
to time the delay. Scans were performed with 3 mm
collimation at a pitch of 1.5–2 and reconstructed at
2 mm. Images were reconstructed in multiplanar
format. The iliac arteries were assessed for suitability
of passage of a stent graft either by CT angiography or
by duplex scanning. If it was necessary to cover the left
subclavian artery, duplex scanning of the carotids was
performed to ensure that the carotid and vertebral
arteries were patent prior to the procedure.
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Eleven patients had atherosclerotic aneurysms.
The diameter of the aneurysms ranged between 6.0
and 9.7 cm (mean 7.4 cm). Two patients presented
with dysphagia, one of whom had a hoarse voice
due to left recurrent laryngeal nerve palsy (Fig. 1).
One patient had evidence of a recent contained
rupture. Nine patients had type B dissection (1
chronic and 8 acute). Six of the patients treated for
acute dissection had evidence of contained rupture
with blood in the pleural space on pre-procedure
CT scans (see Figs. 2–5). One of these patients had,
in addition ischaemia of the right renal artery and
compromised flow in the SMA. The other patients
had acute aneurysmal dilatation of the aorta. The
patient with chronic dissection had a saccular
aneurysm measuring 6.2 cm. One patient with
giant cell arteritis developed a new dissection flap
in the thoracic aorta distal to a previous stent graft
for the treatment of a more proximal dissection.18
Three patients had penetrating ulcers. One of these
patients presented with massive haemoptysis and a
CT scan showed the leaking penetrating ulcer which
was felt to be communicating with the left main
bronchus. One other of these patients showed
evidence of a contained leak. One patient had a
chronic pseudoaneurysm as a result of a road traffic
accident three years previously.
Informed consent was obtained from all patients.
The potential risk of left arm ischaemia was discussed
with those patients who required coverage of the left
subclavian artery. All procedures were performed in
the angiography suite of the radiology department
under general anaesthesia except for two procedures,
which were performed under local anaesthesia. All
patients had a prophylactic dose of 1 g vancomycin iv
Fig. 1. CT scan of 80-year-old patient with recurrent
laryngeal nerve palsy due to 4 cm saccular thoracic
aneurysm. This was successfully excluded following stent
graft deployment.
Fig. 2. CT of 74-year-old patient with a type B dissection with
proven left haemothorax (drained on ITU) due to rupture.
Fig. 3. Angiogram of type B dissection shown in Fig. 2 prior
to stent deployment, showing dissection flap.
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prior to the procedure. Local ethics committee
approval is not required at our institution but all
cases performed are entered into the UK national
registry for thoracic aortic stent grafts as rec-
ommended by Safety and Efficacy Register for New
Interventional Procedures (SERNIP).
A 4F pigtail catheter was inserted into the arch of
the aorta via a left brachial approach to enable
angiography during stent placement, unless it was
planned to cover the left subclavian artery, in which
case a right brachial artery approach was used. The
common femoral artery was punctured following
exposure of the artery via a surgical cut-down. A
260 cm Lunderquist Extra Stiff (Cook) guidewire was
positioned in the arch of the aorta. Five thousand units
of heparin were administered. The stent graft was
passed over the guidewire into the appropriate
position within the arch or descending aorta. Angio-
grams were performed until optimal positioning had
been obtained. One or more stent grafts were deployed
and final angiograms were performed. Surgical clo-
sure of the wound was performed after removal of the
device. The left subclavian artery was covered in seven
patients. One patient required a right to left common
carotid artery bypass prior to the stent graft since it
was necessary to cover the left common carotid artery
as well as the left subclavian.
Twenty-five Gore Xcluder (W Gore, Flagstaff Az.)
stent grafts were deployed in 17 patients, 16 Talent
(Medtronic Ave, Santa Rosa Ca) stent grafts were
deployed in eight patients and five aneurex (Med-
tronic Ave, Santa Rosa Ca) stent grafts were inserted
in two patients. Single devices were deployed in
11 patients. Multiple devices were deployed in 12
patients. Six patients had two stent grafts, four
patients had three stent grafts, one patient had four
stent grafts and one patient had seven stent grafts
inserted.
Patients on the intensive care unit prior to the
procedure returned there for immediate post pro-
cedure care. Otherwise, patients spent a short period
in the recovery room before returning to the ward.
After discharge, all patients had a CT scan within the
first three months. Scans were performed at six and 12
months and annually after that. Plain radiography was
performed on an annual basis to assess the integrity of
the stents. The mean follow-up period was 11 months
(range 1–48 months).
Results
There was one immediate technical failure which
required immediate left ilio-femoral bypass as a result
Fig. 4. Angiogram post stent deployment. The entry site has
been successfully excluded and there are no leaks.
Fig. 5. Follow-up CT scan showing stent graft in the true
lumen and thrombosis of the false lumen.
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of rupture of the external iliac artery. This was in a
patient who had undergone previous aorto-iliac
endarterectomy and had co-existing abdominal and
thoracic aortic aneurysms. The right iliac artery was
considered too tortuous and too small calibre for a
stent graft to pass. The left iliac artery was felt to be
more suitable but this ruptured during passage of the
stent graft. All other procedures were successfully
carried out with no procedural mortality and no other
open conversions. Primary technical success was
defined as a successful stent graft procedure with no
immediate endoleak present. Twenty-five procedures
were performed with no endoleak present immedi-
ately after placement giving a primary technical
success rate of 83%. The 30 day procedural mortality
was 7% (2 of 30 procedures) and the patient mortality
was 8% (2 of 24 patients). There were no neurological
complications and seven patients had the left sub-
clavian artery covered with no incidence of arm
ischaemia. The primary endoleak rate was 36% and
the secondary endoleak rate was 12%. Secondary
endovascular intervention was performed in four of
the 19 patients (21%).
Aneurysms
Nine out of 11 aneurysms were successfully excluded
with no endoleak present at the end of the procedure,
giving a primary technical success rate of 81% (Table
1). In this group there were three deaths, all of which
occurred after 30 days. Two patients died of over-
whelming sepsis after developing infected grafts. The
first of these was admitted six months post procedure,
with fever, pain and septicaemia. A CT scan showed
inflammatory tissue and air surrounding the graft and
the patient died soon after admission. A post mortem
confirmed infection of the graft. The second infected
graft was in a patient with known proximal and distal
leaks who refused further treatment. He presented
two years post procedure with fever, back pain and
malaise. A CT scan showed air in the aneurysm sac
surrounding the graft consistent with infection and he
died soon after. One patient died of unrelated causes at
18 months post procedure. One patient in this group
required open conversion for a ruptured external iliac
artery (see above).
One patient had a small type one endoleak present
immediately post procedure which had sealed by
three months. One patient had a small type one
endoleak detected at one month, which self sealed at
three months. One patient had proximal and distal
leaks at one month with an increase in the size of the
sac diameter. The patient refused further procedures
and the leak and aneurysm sac were stable in
appearance at 18 months but he died at two years as
a result of an infected graft (see above).
Type B dissections
Seven out of eight procedures for acute dissections
were successfully carried out with no leak present
giving a primary technical success rate of 88%
(Table 2). There were two early deaths in this group.
One patient died two days after insertion of three
Gore Xcluder devices. A post mortem revealed a
retrograde dissection into the ascending aorta with a
haemopericardium, which resulted in tamponade
and death. One patient died at home within the first
30 days but no post mortem was performed and the
cause of death is not known. There have been no
late deaths in this group.
One patient had a small type I endoleak present
which had self sealed at one month. A CT scan
carried out after two weeks in one patient showed
continued filling of the false lumen via a re-entry
site distal to the previous stent graft but in the
thoracic aorta. While distal re-entry sites in the
abdomen are not treated, it was felt at the time that
a further stent graft was required. In hindsight, a
watch and wait policy may have been more
appropriate. One patient with known giant cell
arteritis developed a new dissection flap in the
thoracic aorta during follow-up and this was treated
with a further stent graft.
The chronic dissection was successfully performed
with no leak on completion angiography. This patient
with aneurysmal dilatation had three leaks detected
during follow-up (two distal and one proximal) all of
which were treated with three further stent grafts.
There was a small type I endoleak present after his
third procedure but this had sealed at one month. No
leak has been detected at eighteen months following
the most recent procedure.
Penetrating ulcers and traumatic pseudoaneurysm
All three procedures for penetrating ulcers were
successfully carried out. There were no deaths in this
group. One of these patients had a leaking penetrating
ulcer and a CT scan done in the first week showed
continued filling of the ulcer post stent grafting. It was
felt that a further stent graft was required to prevent
further haemorrhage. No further leak has been
detected in either of these patients on further follow-
up. At the end of the procedure for the traumatic
pseudoaneurysm, there was a small type I endoleak
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Table 1. Atherosclerotic aneurysms.
Sex Age Aetiology and site Length of
aneurysm
Device details Immediate outcome Long-term follow-up
F 62 Aneurysm distal descending 13 cm 40 mm Aneurex £ 2 Aneurysm excluded Died cancer oesophagus at 18 months. Sac size
stable
F 79 Aneurysm mid/distal
descending
7 cm 34 £ 150 mm and 34 £ 100 mm Gore Xcluder Aneurysm excluded No leak after 24 months. Sac size reduced
M 76 Aneurysm distal descending 11 cm Talent £ 3 Aneurysm excluded Prox. and dist. endoleaks at 1 month. Refused
intervention. Sac size increased. Died infected
graft 2 years
F 73 Aneurysm distal descending 10 cm 34 £ 150 mm Gore Xcluder Aneurysm excluded No leak after 6 months. Sac size stable
F 73 Aneurysm whole descending 20 cm 40 £ 100 mm, 40 £ 150 mm, 40 £ 200 mm and
37 £ 200 mm Gore Xcluder
Aneurysm excluded No leak after 6 months. Sac size reduced
M 79 Aneurysm proximal
descending
17 cm 34 £ 150 mm Gore Xcluder £ 2 Small leak Small leak immediately. No leak at 6 months.
Sac size stable
M 72 Aneurysm arch and proximal
descending
6 cm 37 £ 150 mm Gore Xcluder Aneurysm excluded No leak after 6 months. Sac size stable
M 53 Aneurysm proximal
descending
6 cm 38 £ 130 mm Talent £ 3 Aneurysm excluded Small leak detected at 1 month. Self sealed at 3
months. Sac size reduced. Died infected graft 6
months
M 81 Aneurysm arch and proximal
descending
3 cm 38 £ 130 mm Talent Aneurysm excluded No leak after 6 months. Sac size stable
M 72 Aneurysm aortic arch 2 cm N/A Ruptured left external
iliac artery
M 72 Aneurysm distal descending 9 cm 3 £ Talent Small leak No leak after 6 months
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present which had sealed at one month. No further
leak has been detected at follow-up.
Follow-up
The follow-up CT scans were assessed in order to
determine the fate of the aneurysms and the false
lumen post stent graft insertion. Of the eight patients
treated for acute dissection, six had follow-up scans
(the two early deaths were in patients treated for
dissection.). Four patients showed total thrombosis of
the false lumen and one showed thrombosis of the
false lumen within the chest but some filling of the
false lumen within the abdomen. One patient showed
reduced residual flow in the thoracic false lumen at
two months with no evidence of further leak. Follow-
up scans were available in 10 of the patients with
atherosclerotic aneurysms. Three patients showed a
reduction in sac size of more than 5 mm, six patients
showed no change in sac size and one had an increase
in sac size. The chronic traumatic pseudoaneurysm
was seen to be thrombosed on follow-up with no
change in size. Of the penetrating ulcers, one
disappeared totally on follow-up, whilst the other
was unchanged.
Nine patients (38%) had evidence of leak/contained
rupture on pre-procedure.
CT scans and were, therefore, treated acutely. Four
of these patients have been the subject of a previous
report.19 Six of these were in patients with a type B
dissection. One of these patients died three days post
procedure but the other five were successful pro-
cedures, which showed no evidence of further leak on
follow-up CT and four of which showed thrombosis of
the false lumen in the thorax. One patient had a 6.2 cm
atherosclerotic aneurysm. Following treatment, the sac
size was unchanged on follow-up but no further leak
was demonstrated. One patient had a leaking pene-
trating ulcer, which was successfully excluded. During
the follow-up period of 12 months, no further leak was
demonstrated but the appearances of the ulcer were
unchanged. One patient had massive haemoptysis due
to leak from a penetrating ulcer into the left main
bronchus. At one month there was no evidence of
further leak and no haemoptysis.
Discussion
Surgical replacement of the descending thoracic aorta
is associated with a significant mortality and morbid-
ity. The reported early mortality rate varies between 3
and 21% depending on the technique used.1 In a studyTa
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by Coselli et al., 198 patients underwent replacement
of the descending thoracic aorta for aneurysmal
disease with an early mortality rate of 5%.2 However,
a recent audit by the Society of Cardiothoracic
Surgeons of Great Britain and Ireland revealed a
mortality rate of 34% for those treated with cardio-
pulmonary bypass and 25% for those treated without.3
The 30 day mortality rate in this series of patients was
7% which is similar to the results of other endovas-
cular series which range from 4 to 14%.4 – 8 Two studies
have compared standard surgical treatment with stent
grafting. Nienaber et al. compared 12 patients who
underwent stent grafting for chronic type B dissection
with 12 matched controls who underwent surgical
treatment. The 30-day mortality in the patients treated
surgically was 8% whilst that in the stent graft group
was 0%. Paraplegia rate, average time in ITU and
average hospital stay were all reduced in the stent
graft group.9 Ehrlich et al. compared the results of 10
patients who underwent stent grafting for aneurysms
of the descending thoracic aorta with 58 patients who
had been previously treated with conventional sur-
gery. The 30-day mortality rate was 31% in the surgical
group and 10% in the stent group. Again, the stent
group showed reduced rate of spinal cord compli-
cations and reduced ITU and hospital stays.10 No
randomised controlled trials have been performed but
these studies suggest a reduced mortality rate when
using stent graft treatment.
In our series no patients developed spinal cord
complications. The incidence of spinal cord compli-
cations in previous series varies from 0 to 3%.4,6 – 10 The
cause of paraplegia in these patients is thought to be
ischaemic in nature and can be treated by prompt
insertion of a CSF drainage catheter. Factors, which
influence the rate of paraplegia have been investigated
by Dake et al. They found that access via the
abdominal aorta, simultaneous surgical repair of an
abdominal aortic aneurysm, previous ascending aortic
aneurysm repair and co-existing ascending aortic
aneurysm all increased the risk of paraplegia.8 The
risk of paraplegia increases with the length of aorta
covered and in our series only one patient had the
whole descending aorta covered.
Seven patients in our series had the left subclavian
artery covered by the stent graft with no ischaemic
symptoms developing as a result. In the series
reported by Taylor et al.,4 three patients had the left
subclavian artery covered by the stent graft with no
long-term symptoms. We, therefore, deduce that the
left subclavian artery can be covered by the stent graft
without the need for prophylactic left common carotid
to subclavian bypass. However, the patient should be
warned that bypass may become necessary if ischae-
mic symptoms develop. It is necessary to ensure that
the carotid and vertebral arteries are intact prior to
covering the left subclavian, since some patients rely
on the left vertebral artery to provide the posterior
cranial circulation.
The main concern with stent grafts is their longevity
and durability. Perigraft endoleaks are a concern in
both the immediate peri-operative period and in the
long-term.13 The endoleak rate for stent grafts in the
descending thoracic aorta has previously been
reported as 24%, most of which occur in the first
year.8 In another series, endoleak occurred in nine out
of 17 patients (52%) treated with a stent graft for
aneurysms of the descending thoracic aorta.14 In our
series, one patient had both distal and proximal type I
endoleaks with increasing sac size on follow-up and
secondary intervention was thought to be warranted.
This patient, however, refused further intervention.
Two patients had secondary procedures performed
within the first 14 days. All the other primary
endoleaks sealed without further intervention within
three months. All the secondary endoleaks occurred in
one patient, all of which required secondary interven-
tion. No other patient has developed a secondary
endoleak.
Endoleaks have been studied more in relation to the
treatment of abdominal aortic aneurysms. A meta-
analysis of previous clinical studies of stent graft
treatment of abdominal aortic aneurysms showed an
endoleak rate of 24%. The majority of these were
detected at the distal attachment site. The fate of the
aneurysm sac showed that overall there was an
increase in diameter in 15%, no change in 35% and
decreased diameter in 50%. However, when those with
an endoleak were considered, there was an increase in
86%, no change in 14% and a decrease in 0%.
Spontaneous thrombosis occurred in 21% of all
endoleaks.12 In the fifth report of the registry for the
endovascular treatment of aneurysms (RETA), the
primary endoleak rate was 14%. In those patients with
a persistent proximal endoleak there was a significant
risk of rupture, justifying an aggressive approach to
their management. The collateral and distal endoleaks
appear to show a more benign course.11 Whether these
findings equate to thoracic stent grafts remains to be
seen. However, in the light of the evidence for type I
leaks in abdominal aortic aneurysms, it is prudent to
treat type I endoleaks in patients with thoracic stent
grafts.
Graft infection is a serious complication which
usually leads to the death of the patient since they are
not suitable candidates for surgical intervention.
However, stent grafts do not invariably become
infected in the presence of active infection. In a series
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of 112 patients who underwent stent grafting for
thoracic aortic aneurysms, three were deployed across
known mycotic aneurysms. No patient developed a
persistent bacteraemia and complete thrombosis of the
aneurysm sacs occurred in all three patients.15 Two
grafts in our series have become infected and patients
died as a consequence. One of these developed two
years post implantation and may have been related to
the presence of chronic distal and proximal leaks. The
other patient presented six months post implantation
and this case is likely to be related to the procedure
itself. This raises the question of where stent grafting
should be performed. Ideally, these procedures would
be performed in a dedicated angiography suite, which
has the sterile conditions of a surgical theatre. Most
operating theatres have the disadvantage of inade-
quate imaging equipment consisting of a mobile image
intensifier with a small field of view. Operating tables
are often incompatible with good imaging and the
range of catheters and wires, which may be required is
not generally available. In addition more contrast
medium is used as the whole field is not visible. As
this is predominantly an image-guided technique, we
perform these procedures in the angiographic suite of
the radiology department. Whilst this does provide
superior imaging, the environment is not ideal from an
infection control point of view. The most effective
solution would be to ensure that theatre type
conditions are incorporated into the design of angio-
graphy suites.
In our institution, a single dose of 1 g intravenous
vancomycin was given to all patients in the pre-
operative period in an attempt to reduce graft
infection. This policy has been changed and two
further doses are now given to cover the post-
operative period. A recent study suggests that stent
grafts are most likely to become infected in the early
post-operative period. This study which was carried
out in dogs following stent graft insertion would
suggest that prophylactic antibiotics should be con-
tinued into the post-operative period.16
The fate of the aneurysm sac is important to assess
during follow-up. Thirty percent of our patients
showed a decrease in size of the aneurysm sac, 60%
showed no change in sac size and 10% (one patient)
showed an increase in size. The patient who showed
an increase in sac size had known distal and proximal
type I endoleaks but had refused further intervention.
Dake et al. showed decrease sac size in 48%, no change
in 26% and an increase in 23%.8 A decrease in sac size
is a re-assuring sign during follow-up, while an
increasing sac size is likely to indicate inadequate
treatment and, therefore, a need for further interven-
tion. However, there is some uncertainty as to the
significance of a stable sac on follow-up. Does this
mean that the aneurysm sac is still being perfused and
if so is there an increased risk of rupture? This will
become more clear over time as longer follow-up
becomes available.
Surgical treatment for rupture of the descending
thoracic aorta carries a particularly high morbidity
and mortality (up to 50%). Stent grafting offers an
alternative treatment in this sub group. In our series,
nine patients with evidence of acute rupture were
treated with a 30-day mortality of 11% (survival rate of
89%). Semba et al. treated 11 patients with evidence of
acute rupture. Two of these patients died in the early
post-operative period, giving a survival rate of 82%
during the follow-up period.17
In conclusion, thoracic stent grafts offer a realistic
alternative to surgery for aneurysmal disease of the
descending thoracic aorta, particularly in those
patients who represent a significant surgical risk.
They are probably the treatment of choice for
traumatic pseudoaneurysms and penetrating ulcers,
as well as complicated type B dissections and acute
aortic rupture when the surgical risk is particularly
high. However, further analysis of the long-term
outcomes is required.
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